4//SEC Filing
Havencrest Healthcare Partners, L.P. 4
Accession 0000899243-24-000121
CIK 0001799191other
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 7:19 PM ET
Size
14.9 KB
Accession
0000899243-24-000121
Insider Transaction Report
Form 4
Havencrest Healthcare Partners, L.P.
10% Owner
Transactions
- Sale
Common stock
2024-01-24$2.30/sh−24,915$57,304→ 27,498 total(indirect: See footnote) - Sale
Common stock
2024-01-26$2.14/sh−6,979$14,935→ 8,637 total(indirect: See footnote) - Sale
Common stock
2024-01-25$2.07/sh−11,882$24,596→ 15,616 total(indirect: See footnote)
Holdings
- 8,801,823(indirect: See footnote)
Common stock
Transactions
- Sale
Common stock
2024-01-25$2.07/sh−11,882$24,596→ 15,616 total(indirect: See footnote) - Sale
Common stock
2024-01-24$2.30/sh−24,915$57,304→ 27,498 total(indirect: See footnote) - Sale
Common stock
2024-01-26$2.14/sh−6,979$14,935→ 8,637 total(indirect: See footnote)
Holdings
- 8,801,823(indirect: See footnote)
Common stock
TOI HC I, LLC
10% Owner
Transactions
- Sale
Common stock
2024-01-24$2.30/sh−24,915$57,304→ 27,498 total(indirect: See footnote) - Sale
Common stock
2024-01-25$2.07/sh−11,882$24,596→ 15,616 total(indirect: See footnote) - Sale
Common stock
2024-01-26$2.14/sh−6,979$14,935→ 8,637 total(indirect: See footnote)
Holdings
- 8,801,823(indirect: See footnote)
Common stock
Footnotes (5)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.15 to $2.44, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.01 to $2.19, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.09 to $2.19, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
- [F4]Havencrest Healthcare Partners GP, LLC (the "General Partner") is the record holder of these shares of the Issuer's common stock.
- [F5]TOI HC I, LLC is the record holder of these 8,801,823 shares of the Issuer's common stock. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. The General Partner controls Havencrest Healthcare Partners, L.P.
Documents
Issuer
Oncology Institute, Inc.
CIK 0001799191
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001705748
Filing Metadata
- Form type
- 4
- Filed
- Jan 25, 7:00 PM ET
- Accepted
- Jan 26, 7:19 PM ET
- Size
- 14.9 KB